Mood Lifters for Undergraduates
ML-UP
1 other identifier
interventional
125
1 country
1
Brief Summary
Large-scale, effective, low-cost, and evidence-based programs that can nimbly translate new research discoveries into prevention and care for psychosocial-based problems are urgently needed since the vast majority of people who need evidence-based care do not receive it. The purpose of this randomized control trial is to investigate the feasibility and efficacy of a Mood Lifters group template specifically for undergraduate students. Mood Lifters is an effective peer-led program that improves or maintains mental health. It seeks to help people enhance pleasure, engagement, and meaning in their lives while minimizing depression, fear, loneliness, and other negative feelings via a proprietary peer-based program that offers weekly meetings and other flexible support options. One obstacle to providing mental health care in the US is that it is costly to provide one-on-one therapy by a licensed professional. This is particularly true in large group settings with limited resources (counseling centers) and a large need for mental health care, like universities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Aug 2023
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2023
CompletedFirst Posted
Study publicly available on registry
January 13, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 18, 2025
CompletedDecember 10, 2025
December 1, 2025
2.2 years
January 4, 2023
December 3, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Patient Health Questionnaire - 9
Assesses Depressive Symptoms (Range 0-27; higher scores indicate more significant symptoms of depression)
through study completion, an average of 1 year
Generalized Anxiety Disorder - 7
Assesses Anxiety Symptoms (Range 0-21; higher scores indicate more significant symptoms of anxiety)
through study completion, an average of 1 year
Study Arms (2)
Treatment Group
EXPERIMENTALIndividuals in this arm will take part in the Mood Lifters program immediately after recruitment.
Waitlist Control Group
NO INTERVENTIONIndividuals in this arm will be invited to take part in the Mood Lifters program after they complete post-treatment surveys as part of the control group.
Interventions
Participants will need to attend 14 hour-long virtual weekly meetings on Zoom that focus on helpful mental health strategies and skills. Participants will be encourage to practice what they learn at home in order to improve their mood or mental wellness.
Eligibility Criteria
You may qualify if:
- undergraduate students
- at least 18 years of age
You may not qualify if:
- active suicidal thoughts or behavior
- active psychosis
- borderline personality disorder
- active mania
- unwillingness to attend all sessions or treatment types (e.g., unwillingness to attend remote)
- non-undergraduate students.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patricia J Deldin, Ph.D.
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 4, 2023
First Posted
January 13, 2023
Study Start
August 1, 2023
Primary Completion
October 18, 2025
Study Completion
October 18, 2025
Last Updated
December 10, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share